US FDA's drug division chief resigns amid ethics concerns and lawsuit

(Reuters) -The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, ...

Trump administration announces Most Favored Nation deal for GLP-1s

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...

FDA Drug Chief’s ‘Revenge’ Emails Revealed in Explosive Lawsuit

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

US FDA awards six more fast-track vouchers to speed drug reviews

The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...

FDA’s top drug regulator sued by drug company, resigns amid conduct probe

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

FDA warns websites selling fake or unapproved forms of Botox, similar drugs

The FDA has sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable ...

Chicken and Beef Croquette Recall Sparks Nationwide Warning

Numerous recalls have been issued this year due to the potential for damaged products and undeclared food allergens.
Disability Scoop

Pediatrics Group Declines To Recommend Drug For Autism Touted By Trump Administration

New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.